US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

402.12

-9.6800-2.35%

Volume:614.99K

Turnover:246.65M

Market Cap:19.93B

PE:38.22

High:422.07

Open:422.07

Low:395.29

Close:411.80

52wk High:625.99

52wk Low:228.00

Shares:49.56M

Float Shares:48.15M

Volume Ratio:1.09

T/O Rate:1.28%

Dividend:0.80

Dividend Rate:0.20%

EPS(TTM):10.52

EPS(LYR):10.52

ROE:25.75%

ROA:11.87%

PB:8.95

PE(LYR):38.22

Loading ...

Overview Company News Filings

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

Navigating the Pitfalls of Offshore Trusts as CRS 2.0 Implementation Approaches

Carpenter Technology: This Stock Will Melt Up -- Barron's

Analysts’ Top Industrial Goods Picks: Carpenter Technology (CRS), Brambles (BMBLF)

Carpenter Technology: This Stock Will Melt Up -- Barrons.com

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)

Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update

Trump's 'Gold Dome' Missile Defense Plan Could Cost $1.2 Trillion Over 20 Years, Report Finds

Poolbeg to Showcase POLB 001 CRS Data at Major Hematology Congress

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

Cellectis Reports Financial Results for the First Quarter 2026

Poolbeg Pharma Wins Canadian Patent for POLB 001 in Cancer CRS Prevention

Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/CRS/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","market":"US","secType":"STK","nameCN":"Carpenter Technology","latestPrice":402.12,"timestamp":1789672698630,"preClose":411.8,"halted":0,"volume":614986,"delay":0,"changeRate":-0.023506556580864514,"floatShares":48145238,"shares":49558566,"eps":10.52,"marketStatus":"Trading","change":-9.68,"latestTime":"09-17 15:18:20 EDT","open":422.07,"high":422.07,"low":395.29,"amount":246649667.583,"amplitude":0.065032,"askPrice":402.12,"askSize":50,"bidPrice":401.19,"bidSize":324,"shortable":3,"etf":0,"ttmEps":10.52,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":411.8,"dividendRate":0.001989,"preHourTrading":{"tag":"盘前","latestPrice":424.2,"preClose":411.8,"latestTime":"08:43 EDT","volume":157,"amount":65504.92945,"timestamp":1789649030531,"change":12.4,"changeRate":0.030112,"amplitude":0.02778},"postHourTrading":{"tag":"盘后","latestPrice":411.8,"preClose":411.8,"latestTime":"19:37 EDT","volume":13323,"amount":5486422.8952,"timestamp":1789601851123,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.094871,"impliedVol":0.4792,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","floatShares":48145238,"roa":"11.87%","roe":"25.75%","lyrEps":10.52,"volumeRatio":1.094871,"shares":49558566,"dividePrice":0.8,"high":422.07,"amplitude":0.065032,"preClose":411.8,"low":395.29,"week52Low":228,"pbRate":"8.95","psRate":"6.38","week52High":625.985,"institutionHeld":0.9356,"latestPrice":402.12,"committee":0.73262,"eps":10.52,"divideRate":0.001989,"volume":614986,"delay":0,"ttmEps":10.52,"open":422.07,"prevYearClose":314.84,"prevWeekClose":443.19,"prevMonthClose":476.42,"prevQuarterClose":616.84,"fiveDayClose":448.25,"twentyDayClose":509.96,"sixtyDayClose":578.12,"dividendPayoutRate":0.0755287009063444,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.010954022070790322},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRS\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"CRS","amount":0.2,"announcedDate":"2026-08-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-25","defaultRemindTime":1787664600000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-08-25","currency":"USD","dateTimestamp":1787630400000,"payDate":"2026-09-03"},{"date":"2026-07-30","symbol":"CRS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":3.03,"defaultRemindTime":1785398400000,"name":null,"time":"Pre-MKt","dateTimestamp":1785384000000,"actualEps":null},{"market":"US","date":"2026-04-29","symbol":"CRS","fiscalQuarterEnding":"2026/03","expectedEps":2.59,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"pre","actualEps":2.77},{"date":"2026-04-28","symbol":"CRS","amount":0.2,"announcedDate":"2026-04-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-04","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-06-04"},{"market":"US","date":"2026-01-29","symbol":"CRS","fiscalQuarterEnding":"2025/12","expectedEps":2.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":2.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRS\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-21","recordDate":"2016-10-25","paymentDate":"2016-12-01","value":0.18,"currency":"USD"},{"executeDate":"2017-02-03","recordDate":"2017-02-07","paymentDate":"2017-03-02","value":0.18,"currency":"USD"},{"executeDate":"2017-04-28","recordDate":"2017-05-02","paymentDate":"2017-06-01","value":0.18,"currency":"USD"},{"executeDate":"2017-08-18","recordDate":"2017-08-22","paymentDate":"2017-09-07","value":0.18,"currency":"USD"},{"executeDate":"2017-10-23","recordDate":"2017-10-24","paymentDate":"2017-12-07","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0.8182,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8182,"analysts":11,"updateTime":1789444800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRS","date":"2026-09-16","current":39.144487,"percent":0.662316,"low":-450.702526,"twenty":-13.465718,"median":33.168874,"eighty":44.087314,"high":137.40172,"avg":3.558958,"sd":101.482309,"marketCap":20582663631},"quantilePoints":[{"date":"2021-09-17","current":-6.609235,"twenty":-6.563514,"median":14.138554,"eighty":34.11215,"marketCap":1517480367},{"date":"2021-09-24","current":-6.841616,"twenty":-6.60093,"median":14.085675,"eighty":34.11215,"marketCap":1570834919},{"date":"2021-10-01","current":-7.170298,"twenty":-6.621574,"median":14.055464,"eighty":34.11215,"marketCap":1646300367},{"date":"2021-10-08","current":-6.973507,"twenty":-6.672026,"median":13.993043,"eighty":34.11215,"marketCap":1601117232},{"date":"2021-10-15","current":-7.048874,"twenty":-6.705955,"median":13.980331,"eighty":34.11215,"marketCap":1618421411},{"date":"2021-10-22","current":-6.705537,"twenty":-6.80716,"median":13.928396,"eighty":34.11215,"marketCap":1539591262},{"date":"2021-10-29","current":-7.541903,"twenty":-6.825286,"median":13.903764,"eighty":34.05528,"marketCap":1488017462},{"date":"2021-11-05","current":-8.00106,"twenty":-6.851665,"median":13.83802,"eighty":34.05528,"marketCap":1578609199},{"date":"2021-11-12","current":-8.31612,"twenty":-6.907352,"median":13.791799,"eighty":34.05528,"marketCap":1640770550},{"date":"2021-11-19","current":-7.480845,"twenty":-6.929962,"median":13.765103,"eighty":34.05528,"marketCap":1475970689},{"date":"2021-11-26","current":-7.146246,"twenty":-6.978113,"median":13.706435,"eighty":34.05528,"marketCap":1409954370},{"date":"2021-12-03","current":-6.884917,"twenty":-6.981881,"median":13.63571,"eighty":34.05528,"marketCap":1358394179},{"date":"2021-12-10","current":-7.224401,"twenty":-6.994861,"median":13.57876,"eighty":33.936368,"marketCap":1425374240},{"date":"2021-12-17","current":-7.458864,"twenty":-7.02802,"median":13.539792,"eighty":33.496912,"marketCap":1471633850},{"date":"2021-12-23","current":-7.077861,"twenty":-7.039534,"median":13.519346,"eighty":33.496912,"marketCap":1396461984},{"date":"2021-12-31","current":-7.12915,"twenty":-7.066051,"median":13.45606,"eighty":33.496912,"marketCap":1406581273},{"date":"2022-01-07","current":-7.932675,"twenty":-7.091184,"median":13.431482,"eighty":33.400404,"marketCap":1565116813},{"date":"2022-01-14","current":-7.974195,"twenty":-7.129269,"median":13.381664,"eighty":33.107884,"marketCap":1573308619},{"date":"2022-01-21","current":-7.114496,"twenty":-7.147711,"median":13.368154,"eighty":32.88775,"marketCap":1403690048},{"date":"2022-01-28","current":-7.029015,"twenty":-7.160249,"median":13.326394,"eighty":32.776514,"marketCap":1386824565},{"date":"2022-02-04","current":-9.851468,"twenty":-7.191153,"median":13.275258,"eighty":32.442808,"marketCap":1395953072},{"date":"2022-02-11","current":-13.193201,"twenty":-7.232126,"median":13.242532,"eighty":32.193446,"marketCap":1869476573},{"date":"2022-02-18","current":-12.968375,"twenty":-7.26807,"median":13.187778,"eighty":31.47225,"marketCap":1837618722},{"date":"2022-02-25","current":-13.165949,"twenty":-7.299087,"median":13.169615,"eighty":17.092068,"marketCap":1865615015},{"date":"2022-03-04","current":-12.474439,"twenty":-7.319765,"median":13.0994,"eighty":16.85449,"marketCap":1767627991},{"date":"2022-03-11","current":-11.871496,"twenty":-7.421217,"median":13.034267,"eighty":16.715734,"marketCap":1682191029},{"date":"2022-03-18","current":-12.954749,"twenty":-7.462036,"median":12.879448,"eighty":16.303153,"marketCap":1835687944},{"date":"2022-03-25","current":-14.504686,"twenty":-7.515082,"median":12.802432,"eighty":16.256541,"marketCap":2055314032},{"date":"2022-04-01","current":-14.766983,"twenty":-7.582461,"median":12.767221,"eighty":16.18078,"marketCap":2092481524},{"date":"2022-04-08","current":-13.779111,"twenty":-7.620731,"median":12.594144,"eighty":16.089337,"marketCap":1952500061},{"date":"2022-04-14","current":-14.463809,"twenty":-7.6687,"median":12.549841,"eighty":15.995398,"marketCap":2049521696},{"date":"2022-04-22","current":-13.768892,"twenty":-7.706324,"median":12.48713,"eighty":15.944544,"marketCap":1951051977},{"date":"2022-04-29","current":-16.93868,"twenty":-7.80714,"median":12.285392,"eighty":15.831326,"marketCap":1842928364},{"date":"2022-05-06","current":-15.430259,"twenty":-7.890014,"median":11.834154,"eighty":15.671927,"marketCap":1678812166},{"date":"2022-05-13","current":-14.732062,"twenty":-7.939552,"median":11.674871,"eighty":15.625444,"marketCap":1602848324},{"date":"2022-05-20","current":-14.403697,"twenty":-7.995198,"median":11.60329,"eighty":15.577684,"marketCap":1567122187},{"date":"2022-05-27","current":-16.023336,"twenty":-8.084816,"median":11.482348,"eighty":15.550272,"marketCap":1743338946},{"date":"2022-06-03","current":-15.535225,"twenty":-8.185212,"median":11.217373,"eighty":15.538022,"marketCap":1690232525},{"date":"2022-06-10","current":-14.314949,"twenty":-8.336657,"median":10.984637,"eighty":15.511601,"marketCap":1557466474},{"date":"2022-06-17","current":-13.130172,"twenty":-8.723615,"median":10.774911,"eighty":15.479597,"marketCap":1428562708},{"date":"2022-06-24","current":-13.121297,"twenty":-8.876021,"median":10.579851,"eighty":15.401151,"marketCap":1427597137},{"date":"2022-07-01","current":-12.158388,"twenty":-9.25749,"median":10.54371,"eighty":15.37648,"marketCap":1322832653},{"date":"2022-07-08","current":-11.577093,"twenty":-9.332781,"median":10.464198,"eighty":15.337478,"marketCap":1259587734},{"date":"2022-07-15","current":-12.25601,"twenty":-9.427235,"median":10.322041,"eighty":15.309248,"marketCap":1333453937},{"date":"2022-07-22","current":-12.517815,"twenty":-9.521691,"median":10.228073,"eighty":15.261138,"marketCap":1361938290},{"date":"2022-07-29","current":-31.602302,"twenty":-9.546869,"median":10.170246,"eighty":15.207938,"marketCap":1551673046},{"date":"2022-08-05","current":-33.490181,"twenty":-9.672279,"median":10.085916,"eighty":15.174821,"marketCap":1644367889},{"date":"2022-08-12","current":-36.675976,"twenty":-9.788172,"median":9.92623,"eighty":15.065191,"marketCap":1800790437},{"date":"2022-08-19","current":-37.521589,"twenty":-9.968368,"median":9.772689,"eighty":15.019966,"marketCap":1842310002},{"date":"2022-08-26","current":-36.754563,"twenty":-10.063588,"median":9.527906,"eighty":15.004808,"marketCap":1804649058},{"date":"2022-09-02","current":-32.101215,"twenty":-10.201618,"median":9.245021,"eighty":14.970589,"marketCap":1576169667},{"date":"2022-09-09","current":-35.308385,"twenty":-10.36067,"median":8.847464,"eighty":14.926403,"marketCap":1733641721},{"date":"2022-09-16","current":-35.446117,"twenty":-10.675455,"median":8.541465,"eighty":14.875756,"marketCap":1740404325},{"date":"2022-09-23","current":-32.789871,"twenty":-11.559344,"median":8.289418,"eighty":14.84909,"marketCap":1609982685},{"date":"2022-09-30","current":-30.635361,"twenty":-11.845143,"median":7.640878,"eighty":14.814116,"marketCap":1504196244},{"date":"2022-10-07","current":-33.389986,"twenty":-12.192577,"median":7.303864,"eighty":14.792584,"marketCap":1639448315},{"date":"2022-10-14","current":-32.927603,"twenty":-12.250128,"median":7.00933,"eighty":14.766319,"marketCap":1616745289},{"date":"2022-10-21","current":-35.701903,"twenty":-12.401516,"median":6.901712,"eighty":14.727355,"marketCap":1752963446},{"date":"2022-10-28","current":-42.377552,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1745955133},{"date":"2022-11-04","current":-45.587616,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1878209781},{"date":"2022-11-11","current":-46.998633,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1936343692},{"date":"2022-11-18","current":-48.197998,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1985757516},{"date":"2022-11-25","current":-48.150964,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1983819719},{"date":"2022-12-02","current":-50.385075,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":2075865079},{"date":"2022-12-09","current":-46.234332,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1904854490},{"date":"2022-12-16","current":-44.01198,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1813293580},{"date":"2022-12-23","current":-44.447044,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1831218202},{"date":"2022-12-30","current":-43.435815,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1789555566},{"date":"2023-01-06","current":-45.846303,"twenty":-12.595028,"median":6.777102,"eighty":14.682147,"marketCap":1888867664},{"date":"2023-01-13","current":-52.442808,"twenty":-12.732349,"median":6.618507,"eighty":14.664985,"marketCap":2160643699},{"date":"2023-01-20","current":-52.066537,"twenty":-12.847955,"median":6.510889,"eighty":14.63597,"marketCap":2145141323},{"date":"2023-01-27","current":-425.668309,"twenty":-12.960199,"median":6.414599,"eighty":14.624201,"marketCap":2383742530},{"date":"2023-02-03","current":-441.347178,"twenty":-13.077381,"median":6.343798,"eighty":14.600968,"marketCap":2471544198},{"date":"2023-02-10","current":-427.400781,"twenty":-13.129156,"median":6.274928,"eighty":14.600968,"marketCap":2393444372},{"date":"2023-02-17","current":-435.283527,"twenty":-13.338316,"median":6.083249,"eighty":14.593148,"marketCap":2437587752},{"date":"2023-02-24","current":-409.729569,"twenty":-13.478662,"median":6.020944,"eighty":14.555551,"marketCap":2294485585},{"date":"2023-03-03","current":-450.702526,"twenty":-13.745087,"median":5.786317,"eighty":14.527768,"marketCap":2523934144},{"date":"2023-03-10","current":-390.759003,"twenty":-13.855323,"median":5.616366,"eighty":14.502617,"marketCap":2188250417},{"date":"2023-03-17","current":-332.547952,"twenty":-13.950796,"median":5.451701,"eighty":14.489684,"marketCap":1862268533},{"date":"2023-03-24","current":-355.156709,"twenty":-14.107889,"median":5.340195,"eighty":14.489684,"marketCap":1988877569},{"date":"2023-03-31","current":-387.727177,"twenty":-14.303115,"median":5.127756,"eighty":14.48846,"marketCap":2171272194},{"date":"2023-04-06","current":-360.354124,"twenty":-14.415719,"median":4.983031,"eighty":14.48846,"marketCap":2017983094},{"date":"2023-04-14","current":-391.538615,"twenty":-14.49651,"median":4.827685,"eighty":14.490909,"marketCap":2192616246},{"date":"2023-04-21","current":-410.422557,"twenty":-14.720939,"median":4.327125,"eighty":14.471026,"marketCap":2298366322},{"date":"2023-04-28","current":126.995225,"twenty":-14.772654,"median":-6.134077,"eighty":14.461866,"marketCap":2616101641},{"date":"2023-05-05","current":117.180335,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2413914899},{"date":"2023-05-12","current":116.75611,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2405175867},{"date":"2023-05-19","current":111.712548,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2301278484},{"date":"2023-05-26","current":108.153773,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2227967714},{"date":"2023-06-02","current":108.884382,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2243018269},{"date":"2023-06-09","current":122.176761,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2516841279},{"date":"2023-06-16","current":122.624554,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2526065813},{"date":"2023-06-23","current":123.001643,"twenty":-14.776435,"median":-6.181961,"eighty":14.441982,"marketCap":2533833842},{"date":"2023-06-30","current":131.109051,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2700846457},{"date":"2023-07-07","current":126.136193,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2598405580},{"date":"2023-07-14","current":137.40172,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2830475435},{"date":"2023-07-21","current":135.304164,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2787265776},{"date":"2023-07-28","current":50.68501,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2858634539},{"date":"2023-08-04","current":49.652027,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2800374324},{"date":"2023-08-11","current":49.565945,"twenty":-14.780872,"median":-6.20838,"eighty":14.471362,"marketCap":2795519306},{"date":"2023-08-18","current":49.809336,"twenty":-14.780872,"median":-6.20838,"eighty":14.502171,"marketCap":2809246524},{"date":"2023-08-25","current":50.051843,"twenty":-14.780872,"median":-6.20838,"eighty":14.549981,"marketCap":2822923955},{"date":"2023-09-01","current":54.243761,"twenty":-14.78531,"median":-6.224066,"eighty":14.53565,"marketCap":3059348110},{"date":"2023-09-08","current":53.741424,"twenty":-14.78531,"median":-6.224066,"eighty":14.597174,"marketCap":3031016290},{"date":"2023-09-15","current":60.046622,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3386629482},{"date":"2023-09-22","current":59.578929,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3360251581},{"date":"2023-09-29","current":59.067931,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3331431281},{"date":"2023-10-06","current":56.634193,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3194168496},{"date":"2023-10-13","current":58.444339,"twenty":-14.78531,"median":-6.224066,"eighty":14.683568,"marketCap":3296260745},{"date":"2023-10-20","current":53.905982,"twenty":-14.78531,"median":-6.224066,"eighty":14.76393,"marketCap":3040297403},{"date":"2023-10-27","current":29.413584,"twenty":-14.798622,"median":-6.243054,"eighty":14.799544,"marketCap":3153136205},{"date":"2023-11-03","current":30.931489,"twenty":-14.798622,"median":-6.243054,"eighty":15.01852,"marketCap":3315855601},{"date":"2023-11-10","current":30.439345,"twenty":-14.798622,"median":-6.243054,"eighty":15.226052,"marketCap":3263097750},{"date":"2023-11-17","current":30.770507,"twenty":-14.798622,"median":-6.243054,"eighty":15.307189,"marketCap":3298598360},{"date":"2023-11-24","current":31.53402,"twenty":-14.798622,"median":-6.243054,"eighty":15.385027,"marketCap":3380446989},{"date":"2023-12-01","current":32.568903,"twenty":-14.798622,"median":-6.243054,"eighty":15.486556,"marketCap":3491386396},{"date":"2023-12-08","current":29.648234,"twenty":-14.794185,"median":-6.241403,"eighty":15.536881,"marketCap":3178290737},{"date":"2023-12-15","current":31.27645,"twenty":-14.794185,"median":-6.241403,"eighty":15.632081,"marketCap":3352835404},{"date":"2023-12-22","current":32.449317,"twenty":-14.794185,"median":-6.241403,"eighty":15.801544,"marketCap":3478566731},{"date":"2023-12-29","current":32.909264,"twenty":-14.798622,"median":-6.243054,"eighty":15.948971,"marketCap":3527873134},{"date":"2024-01-05","current":31.235054,"twenty":-14.79951,"median":-6.24759,"eighty":16.017891,"marketCap":3348397827},{"date":"2024-01-12","current":30.857897,"twenty":-14.79951,"median":-6.24759,"eighty":16.17357,"marketCap":3307966577},{"date":"2024-01-19","current":30.315159,"twenty":-14.800397,"median":-6.252126,"eighty":16.273067,"marketCap":3249785021},{"date":"2024-01-26","current":21.233342,"twenty":-14.79951,"median":-6.24759,"eighty":16.768529,"marketCap":3049107961},{"date":"2024-02-02","current":20.907358,"twenty":-14.79951,"median":-6.24759,"eighty":16.918792,"marketCap":3002296634},{"date":"2024-02-09","current":21.609317,"twenty":-14.79951,"median":-6.24759,"eighty":17.196305,"marketCap":3103097903},{"date":"2024-02-16","current":22.789571,"twenty":-14.79951,"median":-6.24759,"eighty":21.052567,"marketCap":3272582391},{"date":"2024-02-23","current":22.345685,"twenty":-14.79951,"median":-6.24759,"eighty":21.629963,"marketCap":3208840411},{"date":"2024-03-01","current":22.245897,"twenty":-14.798622,"median":-6.243054,"eighty":21.891477,"marketCap":3194510819},{"date":"2024-03-08","current":23.543144,"twenty":-14.798622,"median":-6.243054,"eighty":22.245897,"marketCap":3380795518},{"date":"2024-03-15","current":22.287189,"twenty":-14.798622,"median":-6.243054,"eighty":22.345685,"marketCap":3200440305},{"date":"2024-03-22","current":23.539703,"twenty":-14.798622,"median":-6.243054,"eighty":22.455796,"marketCap":3380301394},{"date":"2024-03-28","current":24.152197,"twenty":-14.798622,"median":-6.243054,"eighty":22.668584,"marketCap":3468255443},{"date":"2024-04-05","current":26.4955,"twenty":-14.79951,"median":-6.24759,"eighty":23.333245,"marketCap":3804753799},{"date":"2024-04-12","current":27.142403,"twenty":-14.79951,"median":-6.24759,"eighty":23.547273,"marketCap":3897649086},{"date":"2024-04-19","current":27.314452,"twenty":-14.79951,"median":-6.24759,"eighty":24.616728,"marketCap":3922355280},{"date":"2024-04-26","current":28.129963,"twenty":-14.798622,"median":-6.243054,"eighty":26.60217,"marketCap":4039462637},{"date":"2024-05-03","current":37.595563,"twenty":-14.798622,"median":-6.243054,"eighty":26.863684,"marketCap":4936297461},{"date":"2024-05-10","current":40.090886,"twenty":-14.798622,"median":-6.243054,"eighty":27.665431,"marketCap":5263933317},{"date":"2024-05-17","current":41.553064,"twenty":-14.798622,"median":-6.243054,"eighty":28.811276,"marketCap":5455917314},{"date":"2024-05-24","current":40.922098,"twenty":-14.798622,"median":-6.243054,"eighty":29.413584,"marketCap":5373071507},{"date":"2024-05-31","current":41.911997,"twenty":-14.798622,"median":-6.243054,"eighty":30.154177,"marketCap":5503045169},{"date":"2024-06-07","current":40.249572,"twenty":-14.798622,"median":-6.243054,"eighty":30.439345,"marketCap":5284768790},{"date":"2024-06-14","current":39.550598,"twenty":-14.79951,"median":-6.24759,"eighty":30.613205,"marketCap":5192993494},{"date":"2024-06-21","current":37.196755,"twenty":-14.800397,"median":-6.252126,"eighty":30.726352,"marketCap":4883933984},{"date":"2024-06-28","current":40.449819,"twenty":-14.80306,"median":-6.267822,"eighty":30.857897,"marketCap":5311061172},{"date":"2024-07-05","current":40.25335,"twenty":-14.80306,"median":-6.267822,"eighty":30.977484,"marketCap":5285264872},{"date":"2024-07-12","current":41.364152,"twenty":-14.80306,"median":-6.267822,"eighty":31.235054,"marketCap":5431113180},{"date":"2024-07-15","current":41.92711,"twenty":-14.80306,"median":-6.267822,"eighty":31.262651,"marketCap":5505029499},{"date":"2024-08-02","current":38.287475,"twenty":-14.910808,"median":-6.366387,"eighty":31.421793,"marketCap":7140614095},{"date":"2024-08-09","current":37.188911,"twenty":-14.910808,"median":-6.366387,"eighty":31.644408,"marketCap":6935731949},{"date":"2024-08-16","current":38.423418,"twenty":-14.910808,"median":-6.366387,"eighty":32.257102,"marketCap":7165967538},{"date":"2024-08-23","current":38.064546,"twenty":-14.910808,"median":-6.366387,"eighty":32.751042,"marketCap":7099037890},{"date":"2024-08-30","current":38.20381,"twenty":-14.910808,"median":-6.366387,"eighty":33.893553,"marketCap":7125010589},{"date":"2024-09-06","current":36.388024,"twenty":-14.910808,"median":-6.366387,"eighty":36.083622,"marketCap":6786366553},{"date":"2024-09-13","current":37.395009,"twenty":-14.910808,"median":-6.366387,"eighty":36.366599,"marketCap":6974169145},{"date":"2024-09-20","current":41.511325,"twenty":-14.910808,"median":-6.366387,"eighty":37.017881,"marketCap":7741862190},{"date":"2024-09-27","current":41.8086,"twenty":-14.910808,"median":-6.366387,"eighty":37.427756,"marketCap":7797303912},{"date":"2024-10-04","current":41.264936,"twenty":-14.910808,"median":-6.366387,"eighty":37.949925,"marketCap":7695910491},{"date":"2024-10-11","current":43.570823,"twenty":-14.910808,"median":-6.366387,"eighty":38.317621,"marketCap":8125958449},{"date":"2024-10-18","current":42.73524,"twenty":-14.910808,"median":-6.366387,"eighty":38.444308,"marketCap":7970122255},{"date":"2024-10-25","current":33.906751,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7710395266},{"date":"2024-10-31","current":34.976887,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7953743991},{"date":"2024-11-08","current":38.315221,"twenty":-14.920651,"median":-6.373244,"eighty":38.775863,"marketCap":8712881178},{"date":"2024-11-15","current":37.699284,"twenty":-14.920651,"median":-6.373244,"eighty":38.959639,"marketCap":8572817127},{"date":"2024-11-22","current":39.610661,"twenty":-14.920651,"median":-6.373244,"eighty":39.15086,"marketCap":9007464289},{"date":"2024-11-29","current":42.532525,"twenty":-14.920651,"median":-6.373244,"eighty":39.285271,"marketCap":9671896246},{"date":"2024-12-06","current":42.712265,"twenty":-14.920651,"median":-6.373244,"eighty":39.549842,"marketCap":9712769029},{"date":"2024-12-13","current":38.834712,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8831013491},{"date":"2024-12-20","current":37.173217,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8453189468},{"date":"2024-12-27","current":38.499344,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8754750859},{"date":"2025-01-03","current":38.468657,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8747772579},{"date":"2025-01-10","current":40.298932,"twenty":-14.930493,"median":-6.380101,"eighty":40.000208,"marketCap":9163977143},{"date":"2025-01-17","current":43.998937,"twenty":-14.930493,"median":-6.380101,"eighty":40.25335,"marketCap":10005358346},{"date":"2025-01-24","current":46.585434,"twenty":-14.930493,"median":-6.380101,"eighty":40.313802,"marketCap":10593527670},{"date":"2025-01-31","current":35.909437,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9652456751},{"date":"2025-02-07","current":35.32268,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9494736407},{"date":"2025-02-14","current":34.0368,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9149091839},{"date":"2025-02-21","current":38.652589,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":10389815982},{"date":"2025-02-28","current":36.887291,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9915303930},{"date":"2025-03-07","current":34.577539,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9294442372},{"date":"2025-03-14","current":32.776935,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8810440080},{"date":"2025-03-21","current":34.596121,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9299437236},{"date":"2025-03-28","current":34.525509,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9280456754},{"date":"2025-04-04","current":30.9466,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8318446005},{"date":"2025-04-11","current":31.173301,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8379383343},{"date":"2025-04-17","current":31.994629,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8600156318},{"date":"2025-04-25","current":27.828327,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9959758217},{"date":"2025-05-02","current":28.141532,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":10071854469},{"date":"2025-05-09","current":29.09428,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":10412842968},{"date":"2025-05-16","current":32.051276,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11471151800},{"date":"2025-05-23","current":31.433729,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11250131518},{"date":"2025-05-30","current":32.461584,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11618000862},{"date":"2025-06-06","current":34.362907,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":12298484481},{"date":"2025-06-13","current":34.557629,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":12368175561},{"date":"2025-06-20","current":34.906739,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":12493121712},{"date":"2025-06-27","current":38.019512,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13607183409},{"date":"2025-07-03","current":38.886026,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13917308715},{"date":"2025-07-11","current":38.488236,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13774939794},{"date":"2025-07-18","current":39.8805,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":14273231018},{"date":"2025-07-25","current":37.966659,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13588267258},{"date":"2025-08-01","current":34.686981,"twenty":-14.955843,"median":-6.442845,"eighty":40.426052,"marketCap":12414470350},{"date":"2025-08-08","current":33.705646,"twenty":-14.955843,"median":-6.442845,"eighty":40.271583,"marketCap":12673322934},{"date":"2025-08-15","current":32.677002,"twenty":-14.955843,"median":-6.442845,"eighty":40.001719,"marketCap":12286552914},{"date":"2025-08-22","current":31.995541,"twenty":-14.955843,"median":-6.442845,"eighty":39.753576,"marketCap":12030323426},{"date":"2025-08-29","current":32.158614,"twenty":-14.955843,"median":-6.442845,"eighty":39.567222,"marketCap":12091639043},{"date":"2025-09-05","current":31.85368,"twenty":-14.968517,"median":-6.445322,"eighty":39.417295,"marketCap":11976983824},{"date":"2025-09-12","current":32.240814,"twenty":-14.955843,"median":-6.442845,"eighty":39.274576,"marketCap":12122546102},{"date":"2025-09-19","current":32.712799,"twenty":-14.955843,"median":-6.442845,"eighty":39.110506,"marketCap":12300012440},{"date":"2025-09-26","current":30.811601,"twenty":-14.955843,"median":-6.442845,"eighty":38.928183,"marketCap":11585162078},{"date":"2025-10-03","current":32.740641,"twenty":-14.955843,"median":-6.442845,"eighty":38.799168,"marketCap":12310480960},{"date":"2025-10-10","current":33.251074,"twenty":-14.955843,"median":-6.442845,"eighty":38.735836,"marketCap":12502403826},{"date":"2025-10-17","current":31.569959,"twenty":-14.955843,"median":-6.442845,"eighty":38.513562,"marketCap":11870304621},{"date":"2025-10-24","current":36.181987,"twenty":-14.955843,"median":-6.366387,"eighty":38.489905,"marketCap":14968488025},{"date":"2025-10-31","current":38.399149,"twenty":-14.955843,"median":-6.295891,"eighty":38.495183,"marketCap":15885727771},{"date":"2025-11-07","current":38.027043,"twenty":-14.955843,"median":-6.239752,"eighty":38.495183,"marketCap":15731787611},{"date":"2025-11-14","current":39.102416,"twenty":-14.955843,"median":20.322393,"eighty":38.688522,"marketCap":16176669691},{"date":"2025-11-21","current":36.775852,"twenty":-14.955843,"median":21.192959,"eighty":38.754291,"marketCap":15214170050},{"date":"2025-11-28","current":38.359409,"twenty":-14.900966,"median":21.781366,"eighty":38.773158,"marketCap":15869287559},{"date":"2025-12-05","current":37.901803,"twenty":-14.800397,"median":21.953414,"eighty":38.773158,"marketCap":15679976036},{"date":"2025-12-12","current":38.77005,"twenty":-14.73513,"median":22.249338,"eighty":38.773158,"marketCap":16039169742},{"date":"2025-12-19","current":38.719473,"twenty":-14.492423,"median":22.359449,"eighty":38.776091,"marketCap":16018245837},{"date":"2025-12-26","current":40.27172,"twenty":-14.427742,"median":22.596876,"eighty":38.842047,"marketCap":16660410453},{"date":"2026-01-02","current":37.913846,"twenty":-14.298255,"median":22.686342,"eighty":38.86133,"marketCap":15684957918},{"date":"2026-01-09","current":38.686959,"twenty":-13.913325,"median":23.374537,"eighty":38.961041,"marketCap":16004794755},{"date":"2026-01-16","current":40.956924,"twenty":-13.791374,"median":23.56379,"eighty":39.008843,"marketCap":16943879550},{"date":"2026-01-23","current":40.312663,"twenty":-13.606078,"median":24.575436,"eighty":39.09025,"marketCap":16677348852},{"date":"2026-01-30","current":35.555907,"twenty":-13.458905,"median":26.60217,"eighty":39.137259,"marketCap":15463264160},{"date":"2026-02-06","current":39.931382,"twenty":-13.458905,"median":26.863684,"eighty":39.1688,"marketCap":17366157832},{"date":"2026-02-13","current":42.145274,"twenty":-13.458905,"median":27.461396,"eighty":39.319195,"marketCap":18328979661},{"date":"2026-02-20","current":43.977777,"twenty":-13.458905,"median":27.678372,"eighty":39.433377,"marketCap":19125935133},{"date":"2026-02-27","current":45.529678,"twenty":-13.458905,"median":28.129963,"eighty":39.548331,"marketCap":19800856799},{"date":"2026-03-06","current":45.239913,"twenty":-13.458905,"median":28.811276,"eighty":39.637841,"marketCap":19674838215},{"date":"2026-03-13","current":43.202399,"twenty":-13.458905,"median":29.078981,"eighty":39.900853,"marketCap":18788723349},{"date":"2026-03-20","current":43.311204,"twenty":-13.458905,"median":29.47538,"eighty":39.999099,"marketCap":18836042580},{"date":"2026-03-27","current":44.852797,"twenty":-13.458905,"median":30.141608,"eighty":40.055602,"marketCap":19506481371},{"date":"2026-04-02","current":46.307346,"twenty":-13.458905,"median":30.356554,"eighty":40.257326,"marketCap":20139064777},{"date":"2026-04-10","current":49.387096,"twenty":-13.458905,"median":30.531334,"eighty":40.31108,"marketCap":21478448067},{"date":"2026-04-17","current":48.808712,"twenty":-13.458905,"median":30.715313,"eighty":40.418388,"marketCap":21226908996},{"date":"2026-04-24","current":48.865978,"twenty":-13.458905,"median":30.931489,"eighty":40.502951,"marketCap":21251813855},{"date":"2026-05-01","current":44.406969,"twenty":-13.458905,"median":30.977484,"eighty":40.825699,"marketCap":21275379058},{"date":"2026-05-08","current":46.163751,"twenty":-13.458905,"median":31.173301,"eighty":41.109259,"marketCap":22117053325},{"date":"2026-05-15","current":44.550084,"twenty":-13.458905,"median":31.262651,"eighty":41.382988,"marketCap":21343945202},{"date":"2026-05-22","current":45.456476,"twenty":-13.458905,"median":31.45123,"eighty":41.50031,"marketCap":21778197451},{"date":"2026-05-29","current":47.913274,"twenty":-13.462311,"median":31.593823,"eighty":41.784397,"marketCap":22955249600},{"date":"2026-06-05","current":51.087719,"twenty":-13.458905,"median":31.685304,"eighty":41.87149,"marketCap":24476126183},{"date":"2026-06-12","current":58.329519,"twenty":-13.458905,"median":31.823788,"eighty":41.955468,"marketCap":27945672469},{"date":"2026-06-18","current":59.679773,"twenty":-13.458905,"median":31.901979,"eighty":42.130392,"marketCap":28592579137},{"date":"2026-06-26","current":62.144868,"twenty":-13.462311,"median":31.992434,"eighty":42.265924,"marketCap":29773606134},{"date":"2026-07-02","current":63.277339,"twenty":-13.462311,"median":32.021372,"eighty":42.335954,"marketCap":30316173017},{"date":"2026-07-10","current":61.284107,"twenty":-13.462311,"median":32.052576,"eighty":42.453334,"marketCap":29361215555},{"date":"2026-07-17","current":57.494684,"twenty":-13.462311,"median":32.107571,"eighty":42.564168,"marketCap":27545703292},{"date":"2026-07-24","current":62.383392,"twenty":-13.462311,"median":32.239489,"eighty":42.72605,"marketCap":29887883042},{"date":"2026-07-31","current":47.238844,"twenty":-13.465718,"median":32.328317,"eighty":42.770723,"marketCap":25027139620},{"date":"2026-08-07","current":52.258985,"twenty":-13.465718,"median":32.454268,"eighty":42.916987,"marketCap":27686810430},{"date":"2026-08-14","current":50.098303,"twenty":-13.465718,"median":32.553703,"eighty":43.216468,"marketCap":26542081192},{"date":"2026-08-21","current":45.749535,"twenty":-13.465718,"median":32.706377,"eighty":43.475372,"marketCap":24238103459},{"date":"2026-08-28","current":45.889848,"twenty":-13.465718,"median":32.784266,"eighty":43.750874,"marketCap":24312441308},{"date":"2026-09-04","current":43.729027,"twenty":-13.465718,"median":32.879521,"eighty":44.031667,"marketCap":23167638433},{"date":"2026-09-11","current":41.930214,"twenty":-13.465718,"median":33.01243,"eighty":44.087314,"marketCap":22214627209},{"date":"2026-09-16","current":38.849875,"twenty":-13.465718,"median":33.168874,"eighty":44.087314,"marketCap":20582663631}],"updateTime":1789641071254},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRS\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640951863","title":"Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951863","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951863?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315200,"startTime":"0","endTime":"0","summary":"One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic anti-tumor activity in metastatic PD-1 relapsed cutaneous melanoma and metas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304266/0/en/Immatics-Presents-Clinical-Activity-and-Response-Dynamics-of-Anzu-cel-PRAME-Cell-Therapy-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU0963586101.USD","BK4006","BK4139","IE00B7SZL793.SGD","IMTX","BK4187","IE00B66KJ199.SGD","LU1169590202.USD","LU2065731478.USD","IE00B19Z4B17.USD","IE0031619046.USD","CRS","BK4023","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639048566","title":"Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2639048566","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639048566?lang=en_us&edition=fundamental","pubTime":"2026-05-31 02:30","pubTimestamp":1780165800,"startTime":"0","endTime":"0","summary":"TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts and reports updated rates of response and disease cont","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303899/0/en/Eikon-Therapeutics-Presents-Data-on-Clinical-Stage-Programs-at-the-2026-Annual-Meeting-of-the-American-Society-of-Clinical-Oncology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","CRS","EIKN","BK4588","L","SSI","BK4139","IE0031619046.USD","BK4107","LU2065731478.USD","ORR","LU0963586101.USD","BK4187","LU2487616109.SGD","AFG","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4585","BK4006","IE00B19Z4B17.USD","LU0210528500.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639095506","title":"Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639095506","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639095506?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142400,"startTime":"0","endTime":"0","summary":"One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer wi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303876/0/en/Immatics-Presents-Clinical-Activity-of-IMA203CD8-PRAME-Cell-Therapy-in-Hard-to-Treat-Gynecologic-Cancers-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","BK4006","LU0963586101.USD","IE0031619046.USD","BK4187","IE00B19Z4B17.USD","LU2065731478.USD","CRS","IMTX","ORR","IE00B66KJ199.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667234","title":"PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667234","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667234?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:00","pubTimestamp":1779966000,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor -targeted CAR T-cell therapy, have been selected for an oral presentation at the 2026 Congress of the European Hematology Association .\"When cancer progresses following CD19 CAR T therapy, patients face a significant unmet medical need, with very limited treatment options remaining,\" said Larry W. Kwak, M.D., Ph.D., scientific founder of PeproMene Bio. \"These durable CRs clinically validate BAFF-R as a novel target, while the favorable safety profile observed to date may support future use in outpatient community oncology settings and further exploration in refractory autoimmune diseases.\". PeproMene Bio, Inc. is a clinical-stage biotech company in Irvine, California developing novel therapies to treat cancers and immune disorders. For more information, c","market":"nz","thumbnail":"https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pepromene-bio-announces-oral-presentation-at-eha-2026-highlighting-favorable-safety-and-durable-responses-with-pmb-ct01-baff-r-car-t-cell-therapy-in-b-cell-lymphomas-including-after-prior-cd19-car-t-cell-failure-302783633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","IE0031619046.USD","BK4006","CAR","CRS.AU","BK4187","LU0963586101.USD","BK4161","LU2065731478.USD","BK4230","IE00B7SZL793.SGD","MRD.AU","IE00B66KJ199.SGD","CR","CRS","BK7095","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131606643","title":"Navigating the Pitfalls of Offshore Trusts as CRS 2.0 Implementation Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=1131606643","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131606643?lang=en_us&edition=fundamental","pubTime":"2026-05-27 12:51","pubTimestamp":1779857496,"startTime":"0","endTime":"0","summary":"The efficacy of an offshore trust hinges on the consistency between its foundational documents and its ongoing operations, ensuring it can withstand multi-dimensional scrutiny including financial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS","IE00B66KJ199.SGD","BK4006","BK4187","IE00B19Z4B17.USD","IE0031619046.USD","LU2065731478.USD","LU0963586101.USD","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637328009","title":"Carpenter Technology: This Stock Will Melt Up -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2637328009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637328009?lang=en_us&edition=fundamental","pubTime":"2026-05-23 09:30","pubTimestamp":1779499800,"startTime":"0","endTime":"0","summary":"Earnings momentum, pricing power, and high barriers to entry underscore the investment case for the specialty alloys maker. By Todd Chanko. Founded in 1889, the Philadelphia-based company manufactures highly specialized, mission-critical alloys used in aerospace, defense, consumer, medical, and other industrial applications. Its investors presentation cites over 30 disparate product categories, ranging from engines, electric vehicles, weaponry, semiconductors, sporting goods, and orthopedics.Only three companies in the world -- all in the U.S. -- have the capabilities to produce these special alloys, so supply is limited. At the same time, demand for such alloys to build aerospace, defense, medical, and industrial gas turbines is growing. This supply/demand imbalance contributed to another quarter of record operating income for Carpenter. The company's adjusted earnings per share rose by 47% in its latest quarter to a record $2.77 on a 12% jump in sales over the same period, to $812 mi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOEG","IE0031619046.USD","IE00B3S45H60.SGD","LU1435385759.SGD","BK4566","LU1929549753.HKD","BK4585","RTX","LU1585245621.USD","EADSY","IE00B66KJ199.SGD","BK4006","LU2326559502.SGD","LU1430594728.SGD","RTXG","BK4550","BA","LU0963586101.USD","BK4588","IE000M9KFDE8.USD","LU0072461881.USD","BK4551","BOED","BK4564","IE00B775SV38.USD","IE00B7SZL793.SGD","BOEU","CRS","LU1366192091.USD","BK4187","LU0640476718.USD","LU0787776722.HKD","LU1280957306.USD","LU0683600562.USD","LU2065731478.USD","IE00B19Z4B17.USD","BK4516","LU0320765646.SGD","LU1162221912.USD","LU0162691827.USD","LU1429558221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637693613","title":"Analysts’ Top Industrial Goods Picks: Carpenter Technology (CRS), Brambles (BMBLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637693613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637693613?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:10","pubTimestamp":1779412236,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Carpenter Technology (CRS) and Brambles (BMBLF...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-industrial-goods-picks-carpenter-technology-crs-brambles-bmblf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-industrial-goods-picks-carpenter-technology-crs-brambles-bmblf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU2065731478.USD","BK4006","BK4187","BMBLF","IE0031619046.USD","IE00B66KJ199.SGD","LU0963586101.USD","CRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333705","title":"Carpenter Technology: This Stock Will Melt Up -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333705?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364800,"startTime":"0","endTime":"0","summary":"Dental implants. Cellphones. Golf clubs. Boeing planes. No, these aren't clues frustrating fans of the popular Connections puzzle. They are, nonetheless, connected: Each one began in the heat of Carpenter Technology's high-tech furnaces.Founded in 1889, the Philadelphia-based company manufactures highly specialized, mission-critical alloys used in aerospace, defense, consumer, medical, and other industrial applications. Its investors presentation cites over 30 disparate product categories, ranging from engines, electric vehicles, weaponry, semiconductors, sporting goods, and orthopedics.Only three companies in the world -- all in the U.S. -- have the capabilities to produce these special alloys, so supply is limited. At the same time, demand for such alloys to build aerospace, defense, medical, and industrial gas turbines is growing. This supply/demand imbalance contributed to another quarter of record operating income for Carpenter. The company's adjusted earnings per share rose by 47","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","EADSY","LU0320765646.SGD","LU0787776722.HKD","LU1430594728.SGD","BOEU","BOEG","LU0640476718.USD","LU1280957306.USD","RTXG","LU2065731478.USD","IE00B775SV38.USD","BA","LU1585245621.USD","IE00B19Z4B17.USD","LU1366192091.USD","BOED","LU0963586101.USD","BK4585","CRS","LU1429558221.USD","LU2326559502.SGD","RTX","LU0162691827.USD","LU1435385759.SGD","BK4564","BK4550","LU1929549753.HKD","IE000M9KFDE8.USD","IE00B3S45H60.SGD","BK4006","BK4516","LU1162221912.USD","BK4588","IE0031619046.USD","LU0072461881.USD","LU0683600562.USD","BK4551","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899893","title":"Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899893","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899893?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:00","pubTimestamp":1779235200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that Dr. Bing Hou has been appointed Chief Scientific Officer, reporting directly to Dr. Jay Mei, Founder, Chairman, and Chief Executive Officer of Antengene.Dr. Hou's appointment underscores Antengene's commitment to strengthening its innovation-driven R&D model as a global biotech company. In this role, Dr. Hou will lead Antengene's efforts across Drug Discovery, Translational Medicine, and Chemistry, Manufacturing and Controls , with a focus on deepening the Company's research engine and building a pipeline of next-generation therapeutic candidates with transformational potential.\"I am honored and excited to step into the role of Chief Scient","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-appoints-dr-bing-hou-as-chief-scientific-officer-to-lead-innovation-driven-rd-strategy-and-advance-next-generation-pipeline-302776389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU0149725797.USD","LU1363072403.SGD","BK4080","IE00B19Z4B17.USD","ADC.AU","IE00BZ1G4Q59.USD","CMC","LU2237443978.SGD","BK4231","BK4006","IND.AU","IE00B7SZL793.SGD","LU2065731478.USD","LU0963586101.USD","IE00BKVL7J92.USD","IE00BFXG1179.USD","IE00BHPRN162.USD","BK4187","DBB","BK7095","LU0882574139.USD","LU2237443382.USD","CRS","LU2237443465.HKD","LU0170899867.USD","IE00B66KJ199.SGD","LU2746668461.USD","LU2237443549.SGD","IE00B1BXHZ80.USD","LU2237443622.USD","IE0031619046.USD","CRS.AU","LU2746668974.SGD","ADC","LU2237443895.HKD","LU0267386448.USD","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636701300","title":"J.P. Morgan Remains a Buy on Carpenter Technology (CRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636701300","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636701300?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:40","pubTimestamp":1779122426,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Bill Peterson maintained a Buy rating on Carpenter Technology yesterday and set a price target of $470.00. Peterson covers the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-carpenter-technology-crs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-carpenter-technology-crs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827948.USD","LU0106261372.USD","BK4006","LU0098860793.USD","LU0267386448.USD","LU1720051017.SGD","LU0390134368.USD","BK4588","LU1732799900.SGD","LU2487616109.SGD","IE00B7SZL793.SGD","LU0912757837.SGD","LU0528227936.USD","LU0210528500.USD","LU2089284900.SGD","LU0234570918.USD","LU1791710400.SGD","LU1244550577.SGD","LU0795875086.SGD","BK4127","LU0320765646.SGD","BK4585","IE00B19Z4B17.USD","CRS","BK4504","LU2065731478.USD","LU2089283258.USD","IE00B66KJ199.SGD","LU2357305700.SGD","LU1363072403.SGD","LU0795875169.SGD","LU1244550494.USD","LU0963586101.USD","LU1988902786.USD","LU1162221912.USD","LU0557290698.USD","LU2133065610.SGD","LU0006306889.USD","LU2028103732.USD","LU1732800096.USD","LU2347655156.SGD","LU1064131342.USD","LU0106831901.USD","LU1989772840.SGD","LU0225283273.USD","LU0053666078.USD","BK4534","BK4516","LU1244550221.USD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772538","title":"Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772538?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:15","pubTimestamp":1778789700,"startTime":"0","endTime":"0","summary":"Announced Cincinnati Children's Applied Gene and Cell Therapy Center  as Lead Manufacturing Partner. Appointed Andrew Fang, Ph.D., as Head of Business Development. BRISBANE, Calif., May 14, 2026  -- Tempest Therapeutics, Inc.  , a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today reported financial results for the quarter ended March 31, 2026, and provided a corporate update.\"We made strong progress in the first quarter as we continued to execute across our lead program TPST-2003,\" said Matt Angel, Ph.D., President and Chief Executive Officer of Tempest. \"We advanced key activities supporting the planned initiation of our U.S. registrational study of TPST-2003 in patients with rrMM, including announcing our lead manufacturing partner AGCTC and taking delivery of the TPST-2003 lentiviral vector, a critical component in the manufacturing of TPST-2003. At the same time, we strengthened our ability to unlock ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","IE00B19Z4B17.USD","BK4006","BK4139","TPST","BK4230","CAR","IE0031619046.USD","PFS","BK4161","BK4211","CR","LU0963586101.USD","BK4187","IE00B7SZL793.SGD","IE00B66KJ199.SGD","EMD","CRS","LU2065731478.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719179","title":"Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719179","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719179?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756400,"startTime":"0","endTime":"0","summary":"AUCATZYL (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quarter of 2026, reflecting strong launches in the US and most recently the UKCompany achieves positive g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294731/0/en/Autolus-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","IE00BKVL7J92.USD","LU1988902786.USD","LU0267386448.USD","ALL","BK4516","LU0912757837.SGD","IE00B66KJ199.SGD","LU0795875169.SGD","LENZ","BK4230","LU0557290698.USD","LU0528227936.USD","LU2264538146.SGD","LU1989772923.USD","LU1668664300.SGD","LU0971096721.USD","LU1732799900.SGD","LU2089283258.USD","LU1244550577.SGD","LU2023251221.USD","BK4534","CAR","LU1548497426.USD","LU1244550221.USD","LU1791710400.SGD","LU0158827781.USD","LU0985320562.USD","LU0963586101.USD","BK4585","LU1720051108.HKD","LU0106261372.USD","LU1074936037.SGD","IE00BZ1G4Q59.USD","BK4539","BK4581","BK4139","LU2111349929.HKD","LU0158827948.USD","LU0098860793.USD","BK4007","LU1064131342.USD","CRS","LU2355687059.USD","LU0106831901.USD","BK4588","LU0320765646.SGD","BK4127","LU2065731478.USD","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719174","title":"Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719174","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719174?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756400,"startTime":"0","endTime":"0","summary":"A single infusion of the lowest dose of rese-cel administered without preconditioning, after discontinuation of all immunomodulators, demonstrated compelling drug-free responses for 6 months in 2 of 4","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294751/0/en/Cabaletta-Bio-Presents-Preconditioning-free-Clinical-Data-and-Automated-Manufacturing-Translational-Data-for-Rese-cel-at-ASGCT-2026-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS","IE00B19Z4B17.USD","BK4209","IE0031619046.USD","IE00B66KJ199.SGD","BK4187","BK4006","IE00B7SZL793.SGD","BK4139","LU2065731478.USD","CABA","PC","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635975806","title":"Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635975806","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635975806?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:02","pubTimestamp":1778702520,"startTime":"0","endTime":"0","summary":"Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, MRD-Guided Consolidation Therapy in 1L Large B-cell Ly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294405/0/en/Allogene-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","CRS","PFS","BK4022","IE00B66KJ199.SGD","BK4007","BK4230","BK4187","BK4139","IE00B19Z4B17.USD","CAR","LENZ","LU2065731478.USD","BK4195","BK4006","IE0031619046.USD","IE00B7SZL793.SGD","BK4539","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144872834","title":"Trump's 'Gold Dome' Missile Defense Plan Could Cost $1.2 Trillion Over 20 Years, Report Finds","url":"https://stock-news.laohu8.com/highlight/detail?id=1144872834","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144872834?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:51","pubTimestamp":1778655064,"startTime":"0","endTime":"0","summary":"A cost estimate report released Tuesday by the U.S. Congressional Budget Office (CBO) indicates that the \"Gold Dome\" national missile defense system proposed by President Trump could cost up to $1.2...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","LU0963586101.USD","BK4006","LU2065731478.USD","CRS","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4187","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635776802","title":"Poolbeg to Showcase POLB 001 CRS Data at Major Hematology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635776802","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635776802?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:09","pubTimestamp":1778652598,"startTime":"0","endTime":"0","summary":"Poolbeg Pharma Ltd. ( ($GB:POLB) ) has shared an update. Poolbeg Pharma said it will present new data on its lead candidate POLB 001 at the Europea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/poolbeg-to-showcase-polb-001-crs-data-at-major-hematology-congress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/poolbeg-to-showcase-polb-001-crs-data-at-major-hematology-congress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0031619046.USD","IE00B66KJ199.SGD","LU2065731478.USD","IE00B19Z4B17.USD","BK4006","IE00B7SZL793.SGD","CRS","BK4187","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242055","title":"Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242055","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242055?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:02","pubTimestamp":1778616120,"startTime":"0","endTime":"0","summary":"Positive pre-BLA meeting with FDA alignment reached on KYSA-8 single-arm trial in stiff person syndrome (SPS); rolling BLA submission initiated Miv-cel pivotal trial primary analysis results in SPS de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293353/0/en/Kyverna-Therapeutics-Announces-Initiation-of-Rolling-SPS-BLA-Submission-and-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","LU2746668974.SGD","IE00B7SZL793.SGD","LU0882574139.USD","LU0149725797.USD","LU0971096721.USD","HCP","BK4022","AAN","LU2237443978.SGD","LU1363072403.SGD","LU0170899867.USD","IE00BKVL7J92.USD","BK4006","IE00BFXG1179.USD","BK4588","IE00B66KJ199.SGD","LU2237443465.HKD","CAR","LU2746668461.USD","CMC","BK4139","IE00BZ1G4Q59.USD","IE00B19Z4B17.USD","LU2237443622.USD","KYTX","BK4230","CRS","LU2237443895.HKD","BK4187","BK4178","IE0031619046.USD","LD","LU0267386448.USD","LU2237443382.USD","LU2065731478.USD","IE00B1BXHZ80.USD","IE00BHPRN162.USD","BK4585","LU2237443549.SGD","CSF","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230959","title":"Cellectis Reports Financial Results for the First Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230959?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:30","pubTimestamp":1778531400,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01 tr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292381/0/en/Cellectis-Reports-Financial-Results-for-the-First-Quarter-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK4006","BK4187","LU0963586101.USD","BK4161","LU2065731478.USD","CLLS","IE00B7SZL793.SGD","IE00B66KJ199.SGD","CR","CRS","BK4139","IE00B19Z4B17.USD","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634774694","title":"Poolbeg Pharma Wins Canadian Patent for POLB 001 in Cancer CRS Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2634774694","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634774694?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:09","pubTimestamp":1778479751,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Poolbeg Pharma Ltd. ( ($GB:POLB) ). Poolbeg Pharma has secured a Canadian patent covering the use of p38 MAPK i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/poolbeg-pharma-wins-canadian-patent-for-polb-001-in-cancer-crs-prevention?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/poolbeg-pharma-wins-canadian-patent-for-polb-001-in-cancer-crs-prevention?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0031619046.USD","BK4187","IE00B19Z4B17.USD","LU2065731478.USD","IE00B66KJ199.SGD","BK4006","LU0963586101.USD","CRS","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633437715","title":"Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633437715","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633437715?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:30","pubTimestamp":1778236200,"startTime":"0","endTime":"0","summary":"Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no pat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3290957/0/en/Artiva-Announces-Positive-Initial-Clinical-Data-with-AlloNK-Across-Multiple-Autoimmune-Diseases-and-FDA-Alignment-to-Initiate-Phase-3-Registrational-Trial-in-Rheumatoid-Arthritis-i.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z4B17.USD","IE00B7SZL793.SGD","LU0963586101.USD","BK4006","CRS","RA","BK4585","IE00B66KJ199.SGD","BK4187","IE0031619046.USD","LU2065731478.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":179,"code":"91000000","status":"200"}]}}